|Chemical and physical data|
|Molar mass||349.449 g·mol−1|
|3D model (JSmol)|
FUB-144 (also known as FUB-UR-144) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is an analogue of UR-144 and XLR-11 where the pentyl chain has been replaced with fluorobenzyl.
Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.